The 20 Best Infantile Neutropenia Doctors Near Me in Bethesda, MD

Dr. Cohen is Director of Pediatric Neuro-Oncology and Clinical Director of the Division of Pediatric Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He received his undergraduate degree at Brown University and earned his MD at the Upstate Medical University, in Syracuse, NY. He did his general Pediatric Residency and Chief Residency at the University of Colorado and completed his Pediatric Hematology/Oncology Fellowship at Johns Hopkins. He has served on the faculty since 1994. His research centers on clinical trials of novel therapeutics for children with brain tumors. Dr. Cohen is co-chair of the High-Grade Glioma committee for the Children's Oncology Group and in that capacity has a particular research interest in the development of therapeutics for the treatment of infiltrating gliomas. He serves on the scientific advisory board for a number of organizations including St. Baldricks and the Childhood Brain Tumor Foundation. He is on the editorial board for PDQ with responsibility for authorship of the pediatric CNS brain tumor summaries. The Pediatric Neuro-Oncology program conducts a broad range of research centered primarily around the development and testing of novel therapeutics for children with brain tumors. The multidisciplinary nature of this work translates into continual collaboration with specialists in pediatric neurosurgery, radiation oncology, neuropathology, neuroradiology, neurology, neuro-ophthalmology, neuropsychology, and other related disciplines. Dr. Cohen is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Glioma, Medulloblastoma, Brain Stem Cancer, Embryonal Tumor with Multilayered Rosettes, and Bone Marrow Aspiration. Dr. Cohen is board certified in American Board Of Pediatrics.

Dr. Bonifant is a pediatric oncologist on the blood and marrow transplantation team at the Sidney Kimmel Comprehensive Cancer Center and an Assistant Professor of Pediatric Oncology at the Johns Hopkins University School of Medicine. She is also a member of the Bloomberg-Kimmel Institute for Immunotherapy. Her clinical specialty is stem cell transplantation for high-risk leukemias. Her research interests are in the areas of immunotherapy of cancer and malignant hematology. Currently, her research focuses on design and development of immune therapies as a treatment for poor-prognosis cancers, including development of engineered cellular immunotherapies for the treatment of Acute Myeloid Leukemia. Dr. Bonifant is a graduate of Wake Forest University and Georgetown University. She completed her Pediatric and Hematology/Oncology training at Johns Hopkins and at Baylor College of Medicine. Prior to her appointment at Johns Hopkins, she was an Assistant Professor in Pediatrics-Hematology/Oncology at the University of Michigan. Dr. Bonifant is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Leukemia, Acute Lymphoblastic Leukemia (ALL), Infantile Neutropenia, and Childhood Acute Myeloid Leukemia. Dr. Bonifant is board certified in American Board Of Pediatrics.

Dr. Aaron M. Milstone is a professor of pediatrics at the Johns Hopkins University School of Medicine. He holds a joint appointments in Epidemiology and Health Policy and Management at the Bloomberg School of Public Health. A pediatric epidemiologist, Dr. Milstone specializes in treating infectious diseases in children. He serves as an associate hospital epidemiologist at The Johns Hopkins Hospital and the pediatric lead for infection prevention for the Johns Hopkins Health System. Dr. Milstone earned his medical degree from Yale University School of Medicine. He completed both a pediatrics residency and a research fellowship in pediatric infectious diseases at Children's Hospital of Philadelphia. He also completed a pediatric infectious diseases fellowship at Johns Hopkins. He holds a M.H.S. (Graduate Training Program in Clinical Investigation) from the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins University School of Medicine. Dr. Milstone joined the Johns Hopkins faculty in 2007. His research interests focus on antibiotic resistance and prevention of healthcare-associated infections. He had led numerous clinical trials including the Pediatric SCRUB Trial and TREAT PARENTS Trial testing strategies to prevent organism transmission and healthcare-associated infections. He is principal investigator of the BrighT STAR Collaborative, guiding hospitals nationwide to reduce over-testing as a strategy to reduce antibiotic use and resistance. Dr. Milstone is a fellow of the American Academy of Pediatrics, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society for Healthcare Epidemiology of America. His many other professional honors include the Pediatric Infectious Diseases Society’s 2014 Young Investigator Award, the inaugural 2013 Caroline B. Hall Clinical Innovation Award, and the Society for Healthcare Epidemiology of America 2018 Mentor Scholar Award, and 2023 Johns Hopkins Medicine Armstrong Award for Excellence in Quality & Safety. Dr. Milstone is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. His clinical expertise encompasses Neonatal Sepsis, Infantile Neutropenia, Parainfluenza, and Premature Infant. Dr. Milstone is board certified in American Board Of Pediatrics.

Dr. John D. Coulson is an assistant professor of pediatrics at the Johns Hopkins University School of Medicine. His area of clinical expertise is pediatric cardiology. He earned his M.D. at University of Michigan Medical School. He completed his medical training and a pediatrics residency at Stanford University Medical Center before training in naval flight surgery at the Naval Aerospace Medical Institute. He then completed fellowships in pediatric cardiology and developmental biology at Stanford. He also served as a medical officer for the U.S. Navy for nine years. Dr. Coulson was an honorary member of the Russian Scientific Society of Interventional Radiology and Endovascular Surgery in 2001. He has published a number of journal articles and co-authored several book chapters related to pediatric cardiology. Dr. Coulson is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. His clinical expertise encompasses Pulmonary Hypertension, Pediatric Myocarditis, Hypertension, and Tetralogy of Fallot. Dr. Coulson is board certified in American Board Of Pediatrics.

Dr. Maureen M. Gilmore is an assistant professor of pediatrics at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include Neonatal-Perinatal Medicine. At Johns Hopkins Children's Center, Dr. Gilmore serves as Medical director of the Level IV Neonatal Intensive Care Unit. She previously was the NICU Medical Director at Johns Hopkins Bayview Medical Center, and her early career was in Neonatology at Penn State University Dr. Gilmore earned her M.D. from the State University of New York Health Science Center at Brooklyn. She completed her Pediatrics residency at the University of Rochester/Strong Memorial Hospital and performed a fellowship in Neonatal -Perinatal Medicine at Johns Hopkins. Her research interests include neuromonitoring and neonatal autoregulation, neonatal abstinenece syndrome, and patient safety. Dr. Gilmore serves on the Perinatal Advisory Committee for the Maryland Institute for Emergency Medical Services Systems. She is a fellow of the American Academy of Pediatrics (AAP) and a member of the Maryland chapter of the AAP. Dr. Gilmore is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. Her clinical expertise encompasses Hypothermia, High Blood Pressure in Infants, Premature Infant, and Necrotizing Enterocolitis. Dr. Gilmore is board certified in American Board Of Pediatrics.

Brenda Banwell is the director of the Department of Pediatrics, as well as pediatrician-in-chief and co-director of Johns Hopkins Children’s Center, where she helps manage the hospital’s many clinical and research centers. Dr. Banwell is a renowned expert in the research and treatment of pediatric multiple sclerosis (MS) and other neuroimmune disorders. She specializes in and studies the use of neuroimaging to assess the clinical and cognitive impact of the conditions, as well as the function of the immune system in children with these disorders. She also created a standardized clinical care algorithm and clinical database in order to evaluate the clinical impact of MS. Dr. Banwell has published more than 250 manuscripts in high-impact journals, along with over 25 book chapters. In addition, she has over 200 national and international invited lectureships and visiting professorships. An advocate for pediatric multiple sclerosis needs and research, Dr. Banwell serves as chair of the International Medical and Scientific Board of the Multiple Sclerosis International Federation, and the Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease (MOGAD) International Research Consortium. She is also chair of the pediatric committee of the National Institutes of Health NeuroNEXT program, which conducts studies on treatments for neurological diseases through academic, private, and industry collaborations. Dr. Banwell currently serves as past-chair of the International Pediatric Multiple Sclerosis Study Group, Dr. Banwell earned her medical degree from the University of Western Ontario. She later completed a residency in pediatrics at the University of Western Ontario-Children's Hospital of Western Ontario and a second residency in pediatric neurology at University of Toronto – The Hospital for Sick Children. Her residencies were followed by a fellowship in neuromuscular research at Mayo Clinic. Dr. Banwell is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Multiple Sclerosis (MS), CACH Syndrome, Optic Neuritis, and Transverse Myelitis. Dr. Banwell is board certified in Royal College Of Physicians And Surgeons Of Canada.

Dr. W. Christopher Golden is an Associate Professor of Pediatrics at the Johns Hopkins University School of Medicine. His area of clinical expertise is neonatology. His research interests include congenital and neonatal infections, neonatal bilirubin metabolism, care of healthy newborns, and pediatric medical education (in particular, medical student education). Currently, he is the Director of the Pediatrics Core Clerkship in the School of Medicine. As Medical Director of the Newborn Nursery, he has been the site Principal Investigator (PI) or a collaborator on research involving improving safe sleep practices in newborns, screening babies for adrenoleukodystrophy and biliary atresia, employing functional MRI (fMRI) to study neonatal cerebral blood flow and oxygen metabolism, using investigational therapies to prevent vertical transmission of HIV, and studying acyclovir pharmacokinetics in neonates with confirmed or suspected herpes simplex virus (HSV) infection. Dr. Golden received his undergraduate degree in zoology from Duke University. He subsequently completed all of his medical training (medical degree, Pediatrics residency and Neonatal-Perinatal Medicine fellowship) at the Johns Hopkins University School of Medicine. Nationally, Dr. Golden is on the Editorial Advisory Board of The Journal of Pediatrics and Contemporary Pediatrics. He also served as Co-Leader of the Core Clerkship Collaborative of the Council on Medical Student Education in Pediatrics (COMSEP), the premier national organization for design, development, and formal academic study of methods in pediatric education in medical schools. Dr. Golden also is the Chair (2023-2025) of the Pediatric Section of the National Medical Association (NMA), the largest and oldest organization representing African American physicians (and their patients) in the United States. At Hopkins, he serves on the Department of Pediatrics Intern Selection Committee and as Core Faculty for the Department of Pediatrics for the Accreditation Council for Graduate Medical Education. Dr. Golden is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Congenital Syphilis, Transient Familial Hyperbilirubinemia, Polydactyly, and Newborn Low Blood Sugar. Dr. Golden is board certified in American Board Of Pediatrics.

Dr. Howard Lederman is a professor of pediatrics at the Johns Hopkins University School of Medicine. He is the director of the Immunodeficiency Clinic, the Pediatric Immunology Laboratory, and the Ataxia-Telangiectasia (A-T) Clinical Center. Dr. Lederman specializes in the evaluation, diagnostic testing and long-term management of patients of all ages who have known or suspected primary immunodeficiency diseases. He is an expert on the use of gamma globulin therapy for a wide variety of disorders. After receiving his M.D. and Ph.D. from the University of Michigan, Dr. Lederman came to Johns Hopkins Children’s Center for a residency in pediatrics, followed by a fellowship in immunology at the Hospital for Sick Children in Toronto. Dr. Lederman’s current research laboratory and clinical research focuses on better understanding and treating patients with ataxia-telangiectasia, a devastating neurological disorder for which there is no cure. He is a member of numerous professional societies, including American Association of Immunologists, the American Society for Microbiology and the Clinical Immunology Society. Dr. Lederman is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Common Variable Immune Deficiency, X-Linked Agammaglobulinemia, Autosomal Dominant Hyper IgE Syndrome, and Hyper IgE Syndrome. Dr. Lederman is board certified in American Board Of Pediatrics.

As a physician scientist in the hematological malignancies and stem cell transplantation division with Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins, my focus is on the various aspects of cellular therapy in the treatment of hematological malignancies. My primary research focus is to develop strategies to prevent relapse of hematological malignancies following allogeneic stem cell transplantation. Additionally, I serve as the director of the adult CAR T program for hematological malignancies as we grow our CAR T program to help patients with advanced hematological malignancies. My academic interest in this space lies in studying the aspects of toxicity of CAR T cell therapy with an aim to improve long term outcomes in these patients. Among hematological malignancies, myeloproliferative disorders are my area of interest and I work to study newer drugs in early phase of development and also its treatment using allogeneic stem cell transplantation. Patient appointments: 410-955-8893. Dr. Jain is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Myelofibrosis, Myeloproliferative Neoplasms (MPN), Splenomegaly, Bone Marrow Transplant, and Splenectomy. Dr. Jain is board certified in American Board Of Internal Medicine.

Valerie Curren is a Pediatric Cardiologist practicing medicine in Baltimore, Maryland. Dr. Curren is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. Her clinical expertise encompasses Infantile Neutropenia. Dr. Curren is board certified in American Board Of Pediatrics.

Recognized as a dedicated and compassionate pediatric hematologist-oncologist, Dr. Keates-Baleeiro cares for patients in the Division of Pediatric Hematology at Johns Hopkins Children’s Center in Baltimore, Maryland. A pediatric hematologist-oncologist is a physician who has special training and experience in diagnosing and treating blood disorders and cancers in children, teens, and young adults. Dr. Keates-Baleeiro’s current clinical interests include pediatric cytopenias, coagulation disorders, platelet disorders, sickle-cell anemia, and hemophilia. Her research interests include rare bleeding disorders, porphyria, and neutropenia in children. Dr. Keates-Baleeiro received her medical degree from the Drexel University College of Medicine in 1999 and completed her internship at Cohen Children’s Medical Center and her pediatric residency at Children’s Hospital of Michigan in Detroit in 2002. She then went on to complete a fellowship in pediatric hematology-oncology at the University of Michigan’s C.S. Mott Children’s Hospital and Vanderbilt University Medical Center in 2003 and 2006, respectively. Passionate about teaching, Dr. Keates-Baleeiro also serves as an Assistant Professor of Pediatrics at the Johns Hopkins School of Medicine educating medical students, pediatric residents, and pediatric hematology oncology fellows. Dr. Keates is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Phosphoglycerate Kinase Deficiency, Sickle Cell Disease, Hemoglobin SC Disease, and Infantile Neutropenia. Dr. Keates is board certified in American Board Of Pediatrics.

Dr. Hilary Vernon is a Professor of Genetic Medicine and pediatrics at the Johns Hopkins University School of Medicine. She is also an attending physician at Kennedy Krieger Institute. Hilary Vernon has expertise in treating inborn errors of metabolism and mitochondrial disorders. She is the director of the Mitochondrial Care Center at The Johns Hopkins Hospital and the Barth Syndrome Interdisciplinary Clinic at the Kennedy Krieger Institute. Her research interests include understanding intermediary metabolism in Barth syndrome and in disorders of branch chain amino acid metabolism. Dr. Vernon also co-directs the Department of Genetic Medicine Clinical Trials Unit, and is the principal investigator on multiple clinical trials for rare diseases. Dr. Vernon received her medical degree and doctorate from Rutgers University, New Brunswick, New Jersey. She completed residencies in genetics and pediatrics at The Johns Hopkins University, and a fellowship in clinical laboratory biochemical genetics at The Johns Hopkins University. Dr. Vernon was recognized with the 2010 Francis F. Schwentker Award for Excellence in Research at Johns Hopkins University and the 2011 James B. Sidbury Jr. Fellowship in Biochemical Genetics at Johns Hopkins University. Dr. Vernon is rated as an Advanced provider by MediFind in the treatment of Infantile Neutropenia. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Methylmalonic Acidemia, Propionic Acidemia, Infantile Neutropenia, and Progressive External Ophthalmoplegia. Dr. Vernon is board certified in American Board Of Medical Genetics And Genomics and American Board Of Pediatrics.

Allan Doctor is a Pediatrics provider practicing medicine in Baltimore, Maryland. Dr. Doctor is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Cerebral Hypoxia, Anemia, High Blood Pressure in Infants, and Infantile Neutropenia.

Sarah Isbey is a Pediatrics provider practicing medicine in Silver Spring, Maryland. Dr. Isbey is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. Her clinical expertise encompasses Multisystem Inflammatory Syndrome in Children (MIS-C), Sudden Infant Death Syndrome (SIDS), Genetic Epilepsy with Febrile Seizures Plus (GEFS+), and Infant Respiratory Distress Syndrome.

Jason Goldstein is a Pediatrics provider practicing medicine in Lutherville, Maryland. Dr. Goldstein is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Respiratory Syncytial Virus (RSV) Infection, Croup, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), and Viral Gastroenteritis.

Sadhana Jackson is a Hematologist and an Oncologist practicing medicine in Bethesda, Maryland. Dr. Jackson is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Gliomatosis Cerebri, Cerebral Hypoxia, Neurofibromatosis, and Embryonal Tumor with Multilayered Rosettes. Dr. Jackson is board certified in American Board Of Pediatrics.

Jenna Bergerson is a Pediatrics provider practicing medicine in Bethesda, Maryland. Dr. Bergerson is rated as an Advanced provider by MediFind in the treatment of Infantile Neutropenia. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Autosomal Dominant Hyper IgE Syndrome, Hyper IgE Syndrome, X-Linked Severe Combined Immunodeficiency, and Severe Combined Immunodeficiency (SCID).

Rohan Hazra is an Infectious Disease provider practicing medicine in Bethesda, Maryland. Dr. Hazra is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. His clinical expertise encompasses Infantile Neutropenia and Zika Virus Disease.

Pranita Tamma is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Tamma is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Osteomyelitis in Children, Bacterial Meningitis, Urinary Tract Infection in Children, and Diarrhea.

Dr. Sick-Samuels grew up in Baltimore, Maryland. She completed her undergraduate degree in Microbiology at the University of Maryland College Park, attended medical school at the Johns Hopkins University School of Medicine, during which time she also obtained a Master’s Degree in Public Health from the Johns Hopkins Bloomberg School of Public Health. She completed pediatrics residency at the Children’s Hospital of Pittsburgh. After completion of fellowship in Pediatric Infectious Diseases at the Johns Hopkins University School of Medicine, she joined the faculty of the division of Pediatric Infectious Diseases. Dr. Sick-Samuels is also an Associate Hospital Epidemiologist in the Department of Hospital Epidemiology and Infection Control at the Johns Hopkins Hospital The focus of Dr. Sick-Samuel’s research is to describe the epidemiology of and to develop effective strategies preventing multidrug-resistant infections in children, particularly healthcare-associated infections. She is investigating how diagnostic stewardship may optimize the use of microbiology testing and associated antibiotic prescribing in hospitalized children. Her other interests include patient safety and quality improvement, and response to emerging or re-emerging infectious such as Zika virus, Measles and respiratory viruses like SARS-COV-2. CV https://www.hopkinsmedicine.org/-/media/Johns%20Hopkins%20Childrens%20Center/documents/CVs/sick-samuels-cv.pdf Research Summary Dr. Sick-Samuels focuses on preventing healthcare-associated infections and diagnostic stewardship to optimize microbiology testing and antibiotic prescribing practices. She leads a multicenter study evaluating impact of clinical decision support to improve respiratory culture practices across 15 hospitals. Dr. Sick is rated as an Experienced provider by MediFind in the treatment of Infantile Neutropenia. Her clinical expertise encompasses Multisystem Inflammatory Syndrome in Children (MIS-C), Pediatric Myocarditis, and Infantile Neutropenia. Dr. Sick is board certified in American Board Of Pediatrics.